Stay updated with breaking news from Diffusion Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage company focused on developing treatments for degenerative diseases of the brain, today announced...
"Astrocytoma Market"DelveInsight's "Astrocytoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Astrocytoma, historical and forecasted epidemiology as well as the
Investment Analysts’ new coverage for Saturday, September 2nd: StockNews.com initiated coverage on shares of Allied Motion Technologies (NASDAQ:AMOT). They issued a buy rating on the stock. StockNews.com initiated coverage on shares of Applied DNA Sciences (NASDAQ:APDN). The firm issued a hold rating on the stock. StockNews.com began coverage on shares of Avid Technology (NASDAQ:AVID). StockNews.com […]
Research analysts at StockNews.com assumed coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Free Report) in a research report issued on Friday. The firm set a “hold” rating on the stock. Diffusion Pharmaceuticals Stock Performance Shares of NASDAQ DFFN opened at $4.40 on Friday. The firm has a 50 day moving average of $4.84 […]
StockNews.com started coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Free Report) in a report issued on Thursday morning. The firm issued a hold rating on the stock. Diffusion Pharmaceuticals Trading Up 11.7 % Shares of DFFN stock opened at $4.40 on Thursday. The company has a fifty day moving average price of $4.94 and […]